Archive - Latest News Search Engine - Global and Local Breaking News

Retiring in Your 50s Is the American Dream for Many — 5 Budget Tips To Make It a Reality

Retiring in Your 50s Is the American Dream for Many — 5 Budget Tips To Make It a Reality

Gold Swings as Traders Weigh Middle East Conflict, Weak Data

Gold Swings as Traders Weigh Middle East Conflict, Weak Data

Independence Blue Cross and Children's Hospital of Philadelphia sign new agreement that reflects their joint commitment to children's health in the region

Independence Blue Cross and Children's Hospital of Philadelphia sign new agreement that reflects their joint commitment to children's health in the region

Solve M.E. Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs

Solve M.E. Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs

Your briefing

Retiring in Your 50s Is the American Dream for Many — 5 Budget Tips To Make It a Reality

Retiring in Your 50s Is the American Dream for Many — 5 Budget Tips To Make It a Reality

Gold Swings as Traders Weigh Middle East Conflict, Weak Data

Gold Swings as Traders Weigh Middle East Conflict, Weak Data

Independence Blue Cross and Children's Hospital of Philadelphia sign new agreement that reflects their joint commitment to children's health in the re...

PHILADELPHIA, June 17, 2025 /PRNewswire/ -- Independence Blue Cross (IBX) and Children's Hospital of Philadelphia (CHOP) have signed a new, multi-year...

Independence Blue Cross and Children's Hospital of Philadelphia sign new agreement that reflects their joint commitment to children's health in the region

Solve M.E. Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs

The Catalyst Award will expedite the hunt for a validated test-to-treat model for ME/CFS, a disease for which there is currently no FDA-approved treat...

Solve M.E. Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs